Medical Device Studies: Clinical Evidence

May 12th, 2019May 13th, 2019
London, --
GB
https://management-forum.co.uk/product/details/2156?referrer=lwjan19_aminnie
Phone:+442077494730
This seminar has been designed specifically for those who are involved in gathering clinical evidence required for medical devices.
Latest in Home
2026 02 27 Marie Pierre Revel Thumbnail
Marie-Pierre Revel looks ahead to lung sessions at ECR 2026
February 27, 2026
Screen Display Mri Machine Adobe Wedmomentsstock
Road to ECR 2026: CT Preview
February 26, 2026
Business Green Environment World
How much solid waste do neurointerventions generate?
February 25, 2026
Brain Stroke
Residents outperform AI on intracranial hemorrhage detection
February 25, 2026
More in Home
Marie-Pierre Revel looks ahead to lung sessions at ECR 2026
By Frances Rylands-Monk
We caught up with thoracic imaging expert Prof. Marie-Pierre Revel to find out what excites her about ECR 2026. She also gave her view on the French radiology strike and reveals her passion for the great outdoors.
February 27, 2026
2026 02 27 Marie Pierre Revel Thumbnail
Road to ECR 2026: CT Preview
By Kate Madden Yee
Attendees at this year's ECR meeting can expect a dynamic program highlighting the modality's many benefits.
February 26, 2026
Screen Display Mri Machine Adobe Wedmomentsstock
How much solid waste do neurointerventions generate?
By Will Morton
Researchers quantified waste generation in their neurointerventional angiography suite over 90 days.
February 25, 2026
Business Green Environment World
Residents outperform AI on intracranial hemorrhage detection
By Maryam Payne
AI software performed well in detecting intracranial hemorrhage on emergency-room CT scans, but it was outperformed by radiology residents, Swiss researchers have reported.
February 25, 2026
Brain Stroke
Marion Smits joins Cambridge team
By Frances Rylands-Monk
Prof. Marion Smits speaks about her new U.K. post at Cambridge University with Prof. Ferdia Gallagher’s group and looks ahead to ECR 2026.
February 24, 2026
2026 02 24 Marion Smits Ferdia Gallagher Thumb
Mammography screening improves survival for late-stage cancers
By Amerigo Allegretto
Women with screen-detected late-stage cancer have greater survival compared with women who do not undergo mammography screening.
February 23, 2026
Mammogram Dense Breasts Cropped
Using GPT‑4o with CT exams helps diagnose ovarian cancer earlier
By Kate Madden Yee
Early detection of ovarian cancer is a persistent challenge, with more than half still diagnosed at metastatic stages.
February 23, 2026
Ovarian Cancer Cells Adobe Justlight
Unclear explanations of contrast MRI exams heighten patient anxiety
By Kate Madden Yee
The good news is that patient anxiety levels can be mitigated by a thoughtful and thorough orientation prior to an examination.
February 23, 2026
Adobe Stock and K.A./peopleimages.com
15 years of top stories: Which are the standouts?
By Philip Ward
To mark the 15th anniversary of AuntMinnieEurope and the retirement of Editor-in-Chief Philip Ward, we present a list of the 15 all-time favorite articles.
February 23, 2026
Top 15 Gold Adobe Hammad
Unfilled vacancies and disparities persist in nuclear medicine
By Maryam Payne
Nuclear medicine specialists have high career satisfaction, but unfilled vacancies and career disparities persist, finds a workforce survey by the European Association of Nuclear Medicine (EANM).
February 19, 2026
Nuclear Medicine Worker Sm
PET develops key clinical role in neuroendocrine tumors
By Edna Astbury-Ward, PhD
Dual PET imaging and the NETPET score are proving increasingly useful in the prognosis and treatment of neuroendocrine tumors.
February 19, 2026
Dual PET imaging in Case Two illustrates a patient with discordant disease. FDG PET (b & d) shows FDG uptake in tail of pancreas primary lesion (yellow arrow), as well as multiple hepatic metastases (yellow boxes), with enlarged liver span. DOTATATE PET on left (a) shows several hepatic metastases that do not demonstrate DOTATATE uptake above background of liver parenchyma. The liver lesions in (c) demonstrate moderate FDG uptake in liver lesions, with no corresponding DOTATATE avidity (white box) or central photopenia (white arrow). This discordance in dual PET imaging corresponds to a NETPET score of 5. This suggests de-differentiated disease and a less favorable prognosis. The patient was not suitable for Lutate treatment and received chemotherapy.
PET/CT visualizes complications in patients on hemodialysis
By Will Morton
F-18 sodium fluoride PET/CT scans can quantify changes in cardiac and aortic vascular calcifications.
February 18, 2026
2026 02 09 Pet Calcification Thumbnail
Page 1 of 72
Next Page